文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

介入肿瘤学与免疫疗法:现状与未来展望

Interventional oncology and immunotherapy: current status and future perspectives.

作者信息

Ma Ji, Wei Zhigang, Ye Xin

机构信息

Department of Oncology, Lung Cancer Center, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China.

Cheeloo College of Medicine, Shandong University, Jinan, China.

出版信息

Front Immunol. 2025 Apr 8;16:1541105. doi: 10.3389/fimmu.2025.1541105. eCollection 2025.


DOI:10.3389/fimmu.2025.1541105
PMID:40264767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011731/
Abstract

Interventional oncology has become an important part of multidisciplinary cancer treatment following the development of interventional radiology. Tumors can release antigens, activate immunity, and cause an abscopal effect after interventional therapy. However, the activated immune response is limited and involves a complex process. New methods to solve the problems were developed following the advent of immunotherapy. The combination therapies enhanced the antitumor immune response and improved patient outcomes with good application prospects. In this review, we have summarized the interventional therapies used to improve immune efficacy and discussed the advancements in combining interventional therapy and immunotherapy.

摘要

随着介入放射学的发展,介入肿瘤学已成为多学科癌症治疗的重要组成部分。肿瘤在介入治疗后可释放抗原、激活免疫并产生远隔效应。然而,激活的免疫反应是有限的,且涉及一个复杂的过程。免疫疗法出现后,人们开发了新的方法来解决这些问题。联合疗法增强了抗肿瘤免疫反应,改善了患者预后,具有良好的应用前景。在这篇综述中,我们总结了用于提高免疫疗效的介入疗法,并讨论了介入疗法与免疫疗法联合应用的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c66d/12011731/47dba098b260/fimmu-16-1541105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c66d/12011731/e1d197452d2d/fimmu-16-1541105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c66d/12011731/47dba098b260/fimmu-16-1541105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c66d/12011731/e1d197452d2d/fimmu-16-1541105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c66d/12011731/47dba098b260/fimmu-16-1541105-g002.jpg

相似文献

[1]
Interventional oncology and immunotherapy: current status and future perspectives.

Front Immunol. 2025-4-8

[2]
Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.

J Vasc Interv Radiol. 2017-11

[3]
PET Assessment of Immune Effects from Interventional Oncology Procedures.

PET Clin. 2019-10

[4]
The evolution of interventional oncology in the 21st century.

Br J Radiol. 2020-8-14

[5]
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends.

Int J Mol Sci. 2023-4-16

[6]
Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies.

J Vasc Interv Radiol. 2024-2

[7]
Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Radiology. 2019-4-23

[8]
Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.

J Cancer Res Clin Oncol. 1995

[9]
Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.

Cardiovasc Intervent Radiol. 2018-9-12

[10]
Combining radiotherapy with immunotherapy: the past, the present and the future.

Br J Radiol. 2017-8

本文引用的文献

[1]
Microwave Ablation Combined with Flt3L Provokes Tumor-Specific Memory CD8 T Cells-Mediated Antitumor Immunity in Response to PD-1 Blockade.

Adv Sci (Weinh). 2025-1

[2]
Cryoablation for treatment of peripheral lung metastases from colorectal cancer: a bicenter retrospective study.

Eur Radiol. 2025-6

[3]
Cryoablation synergizes with anti-PD-1 immunotherapy induces an effective abscopal effect in murine model of cervical cancer.

Transl Oncol. 2025-1

[4]
Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study.

Signal Transduct Target Ther. 2024-10-9

[5]
Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma.

Apoptosis. 2025-2

[6]
Safety and efficacy of CT-guided percutaneous radiofrequency ablation for non-small cell lung cancer: a single-center, single-arm analysis.

Lasers Med Sci. 2024-7-30

[7]
Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model.

Clin Cancer Res. 2024-9-13

[8]
Immunomodulatory effects of microwave ablation on malignant tumors.

Am J Cancer Res. 2024-6-15

[9]
Dynamic Changes in the Immune Microenvironment in Tumor-Draining Lymph Nodes of a Lewis Lung Cancer Mouse Model After Microwave Ablation.

J Inflamm Res. 2024-7-1

[10]
Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment.

ACS Nano. 2024-7-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索